Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Tania Policastro"'
Autor:
Peter A. Barry, Tania Policastro, Pooja Padmanabhan, Stuart James, Paul L. Harris, Jennifer Rusby, Natalie To
Publikováno v:
Cancer Research. 80:P3-08
Background - Involvement of internal mammary lymph nodes (IMLN) in early breast cancer (EBC) leads to an upstaging of the disease anatomically. Unrecognized involvement of IMLNs leading to under-staging and under-treatment has been a hypothesis of st
Autor:
J. Rusby, Elaine Patrick, Tania Policastro, Ashutosh Nerurkar, Katherine Krupa, Peter A. Barry, Nick Low, Pooja Padmanabhan
Publikováno v:
European Journal of Surgical Oncology. 45:893-894
Publikováno v:
European Journal of Surgical Oncology. 44:868
Autor:
Sabino De Placido, Gregory R. Pond, Michele Aieta, Guru Sonpavde, Sisto Perdonà, Giuseppe Di Lorenzo, Carlo Buonerba, Matteo Ferro, Livio Puglia, Tania Policastro, Pasquale Rescigno, Piera Federico, Giovannella Palmieri, Luca Vaccaro, Davide Bosso, Antonella Virtuoso, Michela Izzo
Aim: This study aimed to identify predictive/prognostic factors in castration-resistant prostate cancer patients treated with cabazitaxel. Patients & methods: Patients were enrolled from March 2011 to December 2011 in an international expanded access
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e69eb49620200106d9bd4b38a0eba3a8
http://hdl.handle.net/11588/569137
http://hdl.handle.net/11588/569137
Autor:
Tania Policastro, Piera Federico, Giuseppina Della Vittoria Scarpati, Francesco Perri, Ciro Imbimbo, Ottavio De Cobelli, Sabino De Placido, Carlo Buonerba, Michele Aieta, Davide Bosso, Nicola Longo, Michela Izzo, Matteo Ferro, Giuseppe Di Lorenzo, Livio Puglia
Publikováno v:
Future oncology (London, England). 10(8)
ABSTRACT: Aims: Carboplatin plus etoposide has modest efficacy in docetaxel-pretreated castration-resistant prostate cancer patients. We hypothesized that carboplatin–etoposide could still exert some therapeutic activity after docetaxel, cabazitaxe
Autor:
Tania Policastro, Piera Federico, Giuseppe Di Lorenzo, Livio Puglia, Sabino De Placido, Pasquale Rescigno, Michela Izzo, Davide Bosso, Carlo Buonerba
Prostate cancer is the most common non-cutaneous malignancy for men. The skeleton is the most common metastatic site but, following an improvement in survival, metastases in uncommon sites are being found more frequently in clinical practice, especia
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f342d2df513c1f1db320df1690817d20
https://europepmc.org/articles/PMC4061315/
https://europepmc.org/articles/PMC4061315/
Autor:
Giovannella Palmieri, Mario Delfino, Michela Izzo, Tania Policastro, Elide Matano, Piera Federico, Sabino De Placido, Davide Bosso, Giuseppe Di Lorenzo, Luca Vaccaro, Francesco Perri, Gianfranco Cimmino, Gaia De Fata, Pasquale Rescigno, Carlo Buonerba, Antonella Virtuoso, Rossella Di Trolio
To evaluate the outcomes and potential prognostic factors in patients with non-acquired immunodeficiency syndrome (AIDS)-related Kaposi's sarcoma (KS).Patients with histologically proven non-AIDS-related KS treated with systemic chemotherapy were inc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c8f809248fe11367e10acdc782009c9b
http://hdl.handle.net/11588/569139
http://hdl.handle.net/11588/569139
Autor:
Margaret Ottaviano, Tania Policastro, Giovannella Palmieri, Piera Federico, Lucia Nappi, Davide Bosso, Pasquale Rescigno, Elide Matano, Michela Izzo, Carlo Buonerba, Giuseppe Di Lorenzo
Publikováno v:
Journal of Clinical Oncology. 31:e21500-e21500
e21500 Background: Classic Kaposi Sarcoma (CKS) is a rare and mild form of the disease that primarily affects men, older than 50 years in the endemic areas. Iatrogenic KS (IKS) is associated with the use of steroids, immunosuppressive agents in patie
Autor:
Antonella Virtuoso, Tania Policastro, Piera Federico, Pasquale Rescigno, Giuseppe Di Lorenzo, Michela Izzo, Carlo Buonerba
Publikováno v:
World Journal of Clinical Cases. 1:166
In the case presented here, everolimus was administered after first line therapy with sunitinib in a patient with metastatic renal cell carcinoma. The safety profile was excellent. The prolonged progression-free survival (PFS) obtained with everolimu
Autor:
De Placido S; Pasquale Rescigno, Piera Federico, Carlo Buonerba, Davide Bosso, Livio Puglia, Michela Izzo, Tania Policastro, Sabino De Placido, Giuseppe Di Lorenzo, Genitourinary Cancer Section, Medical Oncology, Department of Clinical Medicine, Federico II University, Napoli 80140, Italy., Rescigno P; Pasquale Rescigno, Piera Federico, Carlo Buonerba, Davide Bosso, Livio Puglia, Michela Izzo, Tania Policastro, Sabino De Placido, Giuseppe Di Lorenzo, Genitourinary Cancer Section, Medical Oncology, Department of Clinical Medicine, Federico II University, Napoli 80140, Italy., Federico P; Pasquale Rescigno, Piera Federico, Carlo Buonerba, Davide Bosso, Livio Puglia, Michela Izzo, Tania Policastro, Sabino De Placido, Giuseppe Di Lorenzo, Genitourinary Cancer Section, Medical Oncology, Department of Clinical Medicine, Federico II University, Napoli 80140, Italy., Buonerba C; Pasquale Rescigno, Piera Federico, Carlo Buonerba, Davide Bosso, Livio Puglia, Michela Izzo, Tania Policastro, Sabino De Placido, Giuseppe Di Lorenzo, Genitourinary Cancer Section, Medical Oncology, Department of Clinical Medicine, Federico II University, Napoli 80140, Italy., Bosso D; Pasquale Rescigno, Piera Federico, Carlo Buonerba, Davide Bosso, Livio Puglia, Michela Izzo, Tania Policastro, Sabino De Placido, Giuseppe Di Lorenzo, Genitourinary Cancer Section, Medical Oncology, Department of Clinical Medicine, Federico II University, Napoli 80140, Italy., Puglia L; Pasquale Rescigno, Piera Federico, Carlo Buonerba, Davide Bosso, Livio Puglia, Michela Izzo, Tania Policastro, Sabino De Placido, Giuseppe Di Lorenzo, Genitourinary Cancer Section, Medical Oncology, Department of Clinical Medicine, Federico II University, Napoli 80140, Italy., Izzo M; Pasquale Rescigno, Piera Federico, Carlo Buonerba, Davide Bosso, Livio Puglia, Michela Izzo, Tania Policastro, Sabino De Placido, Giuseppe Di Lorenzo, Genitourinary Cancer Section, Medical Oncology, Department of Clinical Medicine, Federico II University, Napoli 80140, Italy., Policastro T; Pasquale Rescigno, Piera Federico, Carlo Buonerba, Davide Bosso, Livio Puglia, Michela Izzo, Tania Policastro, Sabino De Placido, Giuseppe Di Lorenzo, Genitourinary Cancer Section, Medical Oncology, Department of Clinical Medicine, Federico II University, Napoli 80140, Italy., Di Lorenzo G; Pasquale Rescigno, Piera Federico, Carlo Buonerba, Davide Bosso, Livio Puglia, Michela Izzo, Tania Policastro, Sabino De Placido, Giuseppe Di Lorenzo, Genitourinary Cancer Section, Medical Oncology, Department of Clinical Medicine, Federico II University, Napoli 80140, Italy.
Publikováno v:
World journal of clinical cases [World J Clin Cases] 2014 Jun 16; Vol. 2 (6), pp. 228-31.